>> Black Swan Analysis Blog

Black Swan Analysis Blog

A look into...Multiple Sclerosis

On March 14, 2014, Tags Epiomic Database, Population, Newsletters

Multiple Sclerosis (MS) affects more than 2.3 million people worldwide; March is Multiple Sclerosis Education Awareness Month®, supported by the Multiple Sclerosis Foundation, with the theme, “MS...

Pharma Company and Agency Team Awards – Nominees 2014-15

On March 12, 2014, Tags News

Congrats to the Black Swan Analysis team for being nominated for this year’s BOBI award for the 'Agency I would most like to work with'. The competition for the top prize is looking tough this year,...

Now Available - USA and EU Hospital Procedure Data

On March 03, 2014, Tags News

Access to the Epiomic Hospital Procedure data for the USA and European Region is now available. As part of our core Epiomic database offering to healthcare clients, we have now made available on-line...

Now available, Atrial Fibrillation video demonstration of the Epiomic database

On December 12, 2013, Tags News, Epiomic Database, Population


Can rare diseases be a viable option for the pharma industry?

On October 15, 2013, Tags Director Articles

In this article, Christopher Ehinger questions whether rare diseases are a viable option for the pharma industry. He looks at the total number of approvals and orphan drug designations in the US...

Defining patient populations is a key trend shaping the pharma industry

On January 14, 2013, Tags Director Articles

Christopher Ehinger of Black Swan Analysis explores one of the key trends in the pharma industry at the moment: defining patient populations. He believes that in order to be successful in the...

Enablers of drug innovation could lie in the numbers

On December 07, 2012, Tags Director Articles

Christopher Ehinger of Black Swan Analysis addresses the problem of clinical-trial recruitment as a barrier to new drug development and offers a new way of looking at the problem.

Forecasting for licensed compounds

On October 14, 2011, Tags Director Articles

Peter Mansell examines the impact of heavier in-licensing/out-licensing traffic on pharma forecasting.

When forecasters take the floor: 6 tips on presenting a forecast

On June 28, 2011, Tags Director Articles

Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast

Forecasting Europe: Whats next for forecasting?

On May 03, 2011, Tags Director Articles

*In the run up to Forecasting Europe [1] in Berlin in June, eyeforpharma asked some of our key speakers for their ins* [1] http://www.eyeforpharma.com/forecastingeu/

New Call-to-action

Subscribe to Email Updates

New call-to-action
RX Brochure CTA Large

Recent Posts

Free Brochure Epiomic